PPG Industries Inc. 10-Q Summary: Quarter Ended March 31, 1994
Business Context and Reporting Period
This Form 10-Q covers the three-month period ended March 31, 1994, for PPG Industries, Inc., a global manufacturer of coatings, glass, and chemicals. The report includes unaudited financial statements and management discussion. Notably, the Board of Directors approved a two-for-one stock split on April 21, 1994, and all share data in this filing has been restated to reflect this distribution.
Key Financial Metrics
| Metric | Q1 1994 | Q1 1993 |
|---|---|---|
| Net Sales | $1,476.9 million | $1,446.7 million |
| Gross Profit | $565.1 million | $532.7 million |
| Gross Margin | 38.3% | 36.8% |
| Net Income | $121.9 million | $(162.7 million) |
| Earnings Per Share (EPS) | $0.57 | $(0.77) |
| Cash from Operations | $83.5 million | $103.5 million |
| Short-term Borrowings | $475.8 million | $355.1 million (Dec 1993) |
| Long-term Debt | $771.9 million | $774.0 million (Dec 1993) |
| Cash and Equivalents | $116.9 million | $111.9 million (Dec 1993) |
Material Changes vs. Prior Period
- Profitability Turnaround: The company reported a net income of $121.9 million in Q1 1994, a significant improvement from a net loss of $162.7 million in Q1 1993. The prior year loss was heavily influenced by a $272.8 million net charge related to three accounting changes (SFAS 106, 109, and 112) and a one-time gain from the sale of an insurance company interest.
- Revenue Growth: Net sales increased by $30.2 million (2.1%) driven by higher volumes across all segments, partially offset by the absence of sales from divested businesses (Biomedicals Systems Division and certain glass businesses) and unfavorable currency translation effects.
- Margin Expansion: Gross profit percentage improved to 38.3% from 36.8%, attributed to lower manufacturing costs, favorable sales mix, and benefits from divested businesses.
- Segment Performance:
- Coatings and Resins: Sales rose to $621 million; operating income increased to $124 million.
- Glass: Sales rose to $568 million; operating income increased to $76 million.
- Chemicals: Sales rose to $288 million, but operating income declined to $36 million due to lower chlor-alkali prices and higher energy costs.
- Balance Sheet: Short-term borrowings increased significantly to $475.8 million from $355.1 million at year-end 1993 to finance seasonal working capital and a stock repurchase program. Accounts receivable increased to $1,221.4 million due to seasonal sales patterns and extended credit terms.
Outlook, Risks, and Unusual Items
- Accounting Changes: The 1993 results included a cumulative effect of accounting changes for postretirement benefits and income taxes. These non-recurring items are not present in the 1994 results, making year-over-year comparisons of net income difficult without adjustment.
- Divestitures: The company is in the process of divesting the Biomedicals Systems Division and has discontinued certain glass businesses, which negatively impacted 1994 sales volumes compared to 1993.
- Market Risks: Management noted unfavorable effects from translating European currencies and lower overall prices in the Chemicals segment. Higher energy costs also impacted the Chemicals segment's operating earnings.
- Stock Split: A 100% stock distribution (two-for-one split) was approved, payable June 10, 1994.
Investor Verification Checklist
- Verify the impact of the two-for-one stock split on share count and per-share metrics for future reporting periods.
- Confirm the timeline and financial impact of the pending divestiture of the Biomedicals Systems Division.
- Monitor the Chemicals segment for continued pressure from lower chlor-alkali prices and rising energy costs.
- Review the sustainability of the gross margin improvement (38.3%) given the offsetting factors of lower sales prices and currency translation.
- Assess the company's liquidity position given the increase in short-term borrowings to $475.8 million.